+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the NOA lens, a custom-made scleral contact lens developed by Azalea Vision BV, to improve visual quality for individuals with keratoconus and presbyopia. This study focuses on a new lens design with a central aperture that aims to enhance image quality by increasing depth of focus and reducing optical aberrations. The NOA lens acts as a functional prototype for future smart lens technology called the ALMA Smart Lens, comparing a standard refractive scleral lens Type 1 with an aperture-integrated lens Type 2 to validate the pinhole effect on vision improvement. The study is a pre-market, interventional, open-label, proof-of-concept trial. Participants first undergo a screening visit including medical history, visual acuity tests, and detailed eye scans like corneal topography and wavefront aberrometry. At baseline, they are fitted with the NOA lens Type 1, which provides standard refractive correction. After settling, various vision assessments are conducted. At the final visit, participants use the NOA lens Type 2, featuring the integrated optical aperture, allowing direct comparison of visual outcomes and higher-order aberrations over approximately six weeks. Participants are monitored for safety throughout the study, which lasts around 12 weeks from screening to completion. Assessments include visual acuity, contrast sensitivity, visual field, and aberrometry measurements. The trial evaluates both effectiveness in reducing optical aberrations for keratoconus and improving near vision for presbyopia, as well as the safety profile by tracking any device-related adverse events.

Age: 18Years +All GendersPhase Not Applicable
2 locations